Ticker Scorecard - VYGR Basics Company: Voyager Therapeutics, Inc. IPO Date: November 11, 2015 Sector: Healthcare Industry: Biotech Market Cap: $230.52M Activated in VL: True Average Daily Range Avg Daily Range: $0.35 | 3.09% Avg Daily Range (30 D): $0.13 | 2.58% Avg Daily Range (90 D): $0.18 | 2.91% Institutional Daily Volume Avg Daily Volume: .46M Avg Daily Volume (30 D): .32M Avg Daily Volume (90 D): .42M Trade Size Avg Trade Size (Sh.): 129 Avg Trade Size (Sh.) (30 D): 85 Avg Trade Size (Sh.) (90 D): 87 Institutional Trades Total Inst.Trades: 551 Avg Inst. Trade: $1.41M Avg Inst. Trade (30 D): $.6M Avg Inst. Trade (90 D): $.67M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.68M Avg Closing Trade (30 D): $.91M Avg Closing Trade (90 D): $.7M Avg Closing Volume: 136.45K     News Feb 19, 2025 @ 11:00 PM Kirby McInerney LLP Announces Investigation Agains... Source: N/A Nov 6, 2024 @ 12:00 PM Voyager Therapeutics to Present at Multiple Upcomi... Source: N/A Oct 14, 2024 @ 5:00 PM Tau Inhibitors Clinical Trial Pipeline Analysis De... Source: Delveinsight Aug 30, 2024 @ 12:59 PM Gene Therapy Market Size to Reach USD 54.39 Billio... Source: Sns Insider Jul 23, 2024 @ 8:03 PM Voyager Therapeutics Announces Inducement Grants U... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.16 $-.18 $-.2 Diluted EPS $-.16 $-.18 $-.2 Revenue $ 24.63M $ 29.58M $ 19.52M Gross Profit $ $ $ Net Income / Loss $ -9.04M $ -10.14M $ -11.33M Operating Income / Loss $ -13.78M $ -15.03M $ -16.18M Cost of Revenue $ $ $ Net Cash Flow $ 36.4M $ -66.95M $ 75.56M PE Ratio